ClinicalTrials.gov
public full text
Public Domain
Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mg
The objective of this study was to investigate the bioequivalence of Mylan's finasteride 5 mg tablets to Merck's Proscar® 5 mg tablets following a single, oral 5 mg (1 x 5 mg) dose administration under fasting conditions.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Finasteride 5 mg Tablets, Non-fasting#1046318
- Fed Study of Finasteride Tablets 5 mg and Proscar® Tablets 5 mg#1096998
- A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fasting Conditions#890727
- Fasting Study of Mercaptopurine 50 mg and Purinethol® Tablets 50 mg#810681
- Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions#966694
Record · ID 1075559
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive